Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation

被引:25
作者
Galy, A [1 ]
Rudraraju, S [1 ]
Baynes, R [1 ]
Klein, J [1 ]
机构
[1] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Stem Cell Transplantat Program, Detroit, MI 48201 USA
关键词
dendritic cells; naive T cells; CD34(+) cell transplant; flow cytometry;
D O I
10.1038/sj.bmt.1702454
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Following high-dose chemotherapy (HDC) and peripheral blood progenitor cell transplantation (PBPCT), there are profound changes in leukocyte homeostasis and the immune system is compromised. Transplantation of purified CD34(+) cells may further compromise immune recovery because the grafts are depleted of mature immune cells. However, a detailed monitoring of immune cell reconstitution has not been done. We monitored blood levels of antigen-presenting cells (APC) and of lymphocytes by multi-color flow cytometry at different times post CD34(+) PBPCT. We found a rapid normalization of circulating levels of the antigen-presenting CD11c(+) dendritic cells (defined as lineage(-) HLA-DR+ CD11c(+) cells). There was a slight over-representation of lin(-) DR+ CD11c(-) cells at day 42 post transplantation suggesting that the composition of the APC population might be affected. Normal levels of total T, B and NK lymphocytes were rapidly achieved but the composition of the T cell population was abnormal. Patients had elevated levels of CD8(+) T cells at early times and a persistent reduction in levels of naive CD8(+) T cells (CD8(+) CD4- CD45RA(+) CD27(+)) and of naive CD4(+) T cells (CD4(+) CD3(+) CD8(-) CD45RA(+)). Thus, we found a rapid recovery of DC after CD34(+) PBPCT but the specific numerical defects in naive T cells are likely to be a major cause of immune dysfunction in the patients.
引用
收藏
页码:1249 / 1255
页数:7
相关论文
共 29 条
[11]   Distinctions between CD8(+) and CD4(+) T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy [J].
Mackall, CL ;
Fleisher, TA ;
Brown, MR ;
Andrich, MP ;
Chen, CC ;
Feuerstein, IM ;
Magrath, IT ;
Wexler, LH ;
Dimitrov, DS ;
Gress, RE .
BLOOD, 1997, 89 (10) :3700-3707
[12]   Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: Comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction [J].
Mapara, MY ;
Korner, IJ ;
Hildebrandt, M ;
Bargou, R ;
Krahl, D ;
Reichardt, P ;
Dorken, B .
BLOOD, 1997, 89 (01) :337-344
[13]  
ODOHERTY U, 1994, IMMUNOLOGY, V82, P487
[14]   Dendritic cell ontogeny: A human dendritic cell lineage of myeloid origin [J].
Olweus, J ;
BitMansour, A ;
Warnke, R ;
Thompson, PA ;
Carballido, J ;
Picker, LJ ;
LundJohansen, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (23) :12551-12556
[15]   HIGH-DOSE COMBINATION ALKYLATING-AGENTS WITH BONE-MARROW SUPPORT AS INITIAL TREATMENT FOR METASTATIC BREAST-CANCER [J].
PETERS, WP ;
SHPALL, EJ ;
JONES, RB ;
OLSEN, GA ;
BAST, RC ;
GOCKERMAN, JP ;
MOORE, JO .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (09) :1368-1376
[16]   ROLE OF CYTOKINES IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].
PETERS, WP ;
ROSS, M ;
VREDENBURGH, J ;
HUSSEIN, A ;
MEISENBERG, B ;
GILBERT, C ;
PETROS, WP ;
KURTZBERG, J .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1993, 7 (03) :737-747
[17]   Expression of pTα mRNA in a committed dendritic cell precursor in the human thymus [J].
Res, PCM ;
Couwenberg, F ;
Vyth-Dreese, FA ;
Spits, H .
BLOOD, 1999, 94 (08) :2647-2657
[18]   Reciprocal control of T helper cell and dendritic cell differentiation [J].
Rissoan, MC ;
Soumelis, V ;
Kadowaki, N ;
Grouard, G ;
Briere, F ;
Malefyt, RD ;
Liu, YJ .
SCIENCE, 1999, 283 (5405) :1183-1186
[19]  
Robinson SP, 1999, EUR J IMMUNOL, V29, P2769, DOI 10.1002/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO
[20]  
2-2